| Microtubule minus-end aster organization is driven by processive HSET-tubulin clusters SR Norris, S Jung, P Singh, CE Strothman, AL Erwin, MD Ohi, M Zanic, ... Nature communications 9 (1), 2659, 2018 | 47 | 2018 |
| Management of acral and mucosal melanoma: medical oncology perspective S Jung, DB Johnson The Oncologist 27 (8), 703-710, 2022 | 17 | 2022 |
| Alopecia areata: current treatments and new directions D Dahabreh, S Jung, Y Renert-Yuval, J Bar, E Del Duca, ... American Journal of Clinical Dermatology 24 (6), 895-912, 2023 | 14 | 2023 |
| Biomarkers of immune checkpoint inhibitor response and toxicity: Challenges and opportunities RS Goodman, S Jung, JM Balko, DB Johnson Immunological Reviews 318 (1), 157-166, 2023 | 8 | 2023 |
| Recurrence of hypophysitis after immune checkpoint inhibitor rechallenge BC Park, S Jung, JJ Wright, DB Johnson The Oncologist 27 (12), e967-e969, 2022 | 7 | 2022 |
| Clinical and genomic correlates of imatinib response in melanomas with KIT alterations S Jung, E Armstrong, AZ Wei, F Ye, A Lee, MS Carlino, RJ Sullivan, ... British Journal of Cancer 127 (9), 1726-1732, 2022 | 7 | 2022 |
| Challenging dermatologic considerations associated with immune checkpoint inhibitors BC Park, S Jung, ST Chen, AK Dewan, DB Johnson American Journal of Clinical Dermatology 23 (5), 707-717, 2022 | 5 | 2022 |
| Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort … X Bai, A Shaheen, C Grieco, PD d’Arienzo, F Mina, JA Czapla, ... EClinicalMedicine 65, 2023 | 4 | 2023 |
| Cross-sectional study of psoriasis, atopic dermatitis, rosacea, and alopecia areata suggests association with cardiovascular diseases AD Pagan, S Jung, S Caldas, J Ungar, N Gulati, B Ungar Journal of drugs in dermatology: JDD 22 (6), 576-581, 2023 | 3 | 2023 |
| Benefit, recurrence pattern, and toxicity to adjuvant anti-PD-1 monotherapy varies by ethnicity and melanoma subtype: An international multicenter cohort study X Bai, AR Lawless, JA Czapla, SC Gerstberger, BC Park, S Jung, ... JAAD international 15, 105-114, 2024 | 2 | 2024 |
| Therapeutic responses to combination nivolumab and temozolomide as salvage therapy for metastatic melanoma: a case series RS Goodman, S Jung, J Quintos, DB Johnson The Oncologist 28 (9), e839-e842, 2023 | 1 | 2023 |
| Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study E David, N Shokrian, E Del Duca, M Meariman, J Glickman, S Ghalili, ... Archives of Dermatological Research 316 (7), 487, 2024 | | 2024 |
| Correction: Association of alopecia areata and ischemic heart disease and cerebrovascular disease in US adults: an All of Us database study S Caldas, AD Pagan, J Pulsinelli, JC da Rosa, S Jung, D Sharma, ... Archives of dermatological research 316 (7), 448, 2024 | | 2024 |
| Association of alopecia areata and ischemic heart disease and cerebrovascular in US adults: an all of us database study S Caldas, AD Pagan, J Pulsinelli, JC da Rosa, S Jung, D Sharma, ... Archives of Dermatological Research 316 (5), 1-3, 2024 | | 2024 |
| Primary Tumor Characteristics as Biomarkers of Immunotherapy Response in Advanced Melanoma: A Retrospective Cohort Study RS Goodman, S Jung, K Fletcher, H Burnette, I Mohyuddin, R Irlmeier, ... Cancers 16 (13), 2355, 2024 | | 2024 |
| Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort … X Bai, A Shaheen, C Grieco, PD d’Arienzo, F Mina, JA Czapla, ... Eclinicalmedicine 71, 2024 | | 2024 |
| Prognostic Risk Stratification and End-of-Life Care Outcomes in Patients With Metastatic Melanoma Treated With Immune Checkpoint Inhibitors RN Grad, S Jung, F Ye, L Sun, DB Johnson, R Agarwal The Oncologist 28 (10), 911-916, 2023 | | 2023 |
